trans-4-(Aminomethyl)cyclohexane carboxylic acid methylamide (t-AMCHA methylamide) inhibits the physical interaction between urokinase-type plasminogen activator and stratum corneum, and accelerates the recovery of barrier function.
Katsuta
Yuji
Y
Yoshida
Yuzo
Y
Kawai
Eriko
E
Suetsugu
Masaru
M
Kohno
Yoshiyuki
Y
Inomata
Shinji
S
Kitamura
Kenji
K
D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D020127:Recovery of Function / Q000187:drug effects; D012867:Skin / Q000187:drug effects* / Q000378:metabolism*; D014148:Tranexamic Acid / Q000494:pharmacology*; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors* / Q000378:metabolism
D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid; D014568:Urokinase-Type Plasminogen Activator